Tuberculosis in children

Current Problems in Pediatric and Adolescent Health Care

Volumn 31, Issue 1, 2001, Pages 5-103

  Smith, Kim Connelly ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CHILD; DISEASE TRANSMISSION; FEMALE; HUMAN; LUNG TUBERCULOSIS; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; TUBERCULIN TEST; TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTITUBERCULAR AGENTS; BCG VACCINE; CHILD; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 33845876964     PISSN: 15385442     EISSN: None     Source Type: Journal    
DOI: 10.1067/mps.2001.112814     Document Type: Article

References (103)

1. Medical Research Council Investigation. Streptomycin treatment of pulmonary tuberculosis. Br Med J 1948;2:769-82.
2. Centers for Disease Control and Prevention. A strategic plan for the elimination of tuberculosis from the United States. MMWR 1989;38(Suppl No.S-3).
3. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991;72:1-6.
4. World Health Organization. Groups at risk: WHO report on the tuberculosis epidemic. Geneva (Switzerland): World Health Organization; 1996.
5. Sudre P, Dam GT, Kochi A. Tuberculosis: a global overview of the situation today. Bull World Health Organ 1992;70:149-59.
6. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 1998. August 1999. Available from: www.cdc.gov/nchstp/tb/surv/surv98.htm
7. McKenna MT, McCray E, Onorato IM. The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med 1995;332:1071-6.
8. Centers of Disease Control and Prevention. Core curriculum on tuberculosis: what a clinician should know. 4th ed. Atlanta (GA): US Dept of Health and Human Services; 2000.
9. O'Reilly L, Dabom C. The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tuber Lung Dis 1995;76(Suppl 1):1-46.
10. Riley R. Airborne infection. Am J Med 1974;57:466-75.
11. Leggiadro RJ, Collery B, Dowdy S. Outbreak of tuberculosis in a family day care home. Pediatr Infect Dis J 1989;8:52-4.
12. Smith KC. Tuberculosis exposure in a day-care center: recommended management. South Med J 2000;93:877-80.
13. Aznar J, Sari H, Romero J, Alejo A, Gracia A, Palomares JC. Nosocomial transmission of tuberculosis infection in pediatrics wards. Pediatr Infect Dis J 1995;14:44-8.
14. Wallgreen A. On contagiousness of childhood tuberculosis. Acta Paediatr 1937;22:229-34.
15. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR 1994;43(RR-13):1-133.
16. Dannenberg AM. Pathogenesis of pulmonary tuberculosis: Host-parasite interactions, cell-mediated immunity, and delayed-type hypersensitivity. In: Schlossberg D, editor. Basic principles in tuberculosis. 3rd ed. New York: Springer-Verlag; 1992.
17. Ferrebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Adv Tuberc Res 1970; 17:28-106.
18. Miller FJW, Seale RME, Taylor MD. Tuberculosis in children. Boston: Little, Brown; 1963.
19. Selwyn PA, Sckell BM, Alcabes P, et al. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 1992;268(4):504-9.
20. Vallejo JG, Ong LT, Starke JR. Clinical features, diagnosis, and treatment of tuberculosis in infants. Pediatrics 1994;94:1-7.
21. Starke JR, Taylor-Watts KT. Tuberculosis in the pediatric population of Houston, Texas. Pediatrics 1989;84:28-35.
22. Ghon A. The primary lung focus of tuberculosis in children. London: J A Churchill; 1916.
23. Sokal JE. Measurement of delayed skin-test responses. N Engl J Med 1975;293:501-2.
24. Bouros D, Zeros G, Panaretos C, Vassilatos C, Siafakas N. Palpation.vs pen method for the measurement of skin tuberculin reaction (Mantoux test). Chest 1991;99:416-9.
25. American Academy of Pediatrics. Tuberculosis. In: Picketing LK, editor. 2000 Red Book: Report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village (IL):American Academy of Pediatrics; 2000. p. 596.
26. American Thoracic Society and Centers for Disease Control and Prevention. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-95.
27. American Academy of Pediatrics. Measles. In: Picketing LK, editor. 2000 Red Book: Report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village (IL): American Academy of Pediatrics; 2000. p. 394.
28. Holden M, Dubin MR, Diamond PH. Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med 1971;285:1506-9.
29. Gurkan F, Bosnak M, Dikici B, et al. Miliary tuberculosis in children: a clinical review. Scand J Infect Dis 1998;30:359-62.
30. Mezies R, Vissandjee B. Effect of Bacille Calmette-Guérin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992;145:621-5.
31. Karalliede S, Katugha LP, Uragoda CG. The tuberculin response of Sri Lankan children after BCG vaccination at birth. Tubercle 1987;68:33-8.
32. Connelly KK. Bacille Calmette-Guérin vaccine. Sem Pediatr Infect Dis 1993;4:299-306.
33. Bass JB Jr, Serio RA. The use of repeat skin tests to eliminate the booster phenomenon in serial tuberculin testing. Am Rev Respir Dis 1981;123:394-6.
34. Centers for Disease Control and Prevention. Anergy skin testing and preventive therapy for HIV-infected persons: revised recommendations. MMWR 1997;46:1-10.
35. American Thoracic Society and Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-S247.
36. Fergusson JAE, Simpson E. Surgical treatment of atypical mycobacterial cervicofacial adenitis in children. Aust N Z J Surg 1999;69:426-9.
37. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:S1-S25.
38. Sumaya CV, Simek M, Smith MHD, et al. Tuberculous meningitis in children during the isoniazid era. J Pediatr 1975;87:43-9.
39. Hobby GL, Holman AP, Iseman MD, Jones J. Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis. Antimicrob Agents Chemother 1973;4:94-104.
40. Yeager HJ, Lacy J Jr, Smith L, LeMaistre C. Quantitative studies of mycobacterial populations in sputum and saliva. Am Rev Respir Dis 1967;95:998-1004.
41. Braun M. Pediatric tuberculosis, bacilli Calmette-Guérin immunization and acquired immunodeficiency syndrome. Semin Infect Dis 1993;4:261-8.
42. Pomputius W, Rost J, Dennehy PH, Carter EJ. Standardization of gastric aspirate technique improves yield in the diagnosis of tuberculosis in children. Pediatr Infect Dis J 1997;16:222-6.
43. Morgan MA, Horstmeier CD, DeYoung DR, Robers GD. Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens. J Clin Microbiol 1983;18:384-8.
44. Shinnick T, Good R. Diagnostic mycobacteriolgy laboratory practices. Clin Infect Dis 1995;21:291-9.
45. American Thoracic Society. Rapid diagnostic tests for tuberculosis: what is the appropriate use? Am J Respir Crit Care Med 1997;155:1804-14.
46. Smith KC, Starke JR, Eisenach K, et al. Detection of Mycobacterium tuberculosis in clinical specimens from children using a polymerase chain reaction. Pediatrics 1996;97:155-60.
47. Catanzaro A, Perry S, Clarridge JE, et al. The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial. JAMA 2000;283:639-45.
48. Perry S, Catanzaro A. Use of clinical risk assessments in evaluation of nucleic acid amplification tests for HIV/Tuberculosis. Int J Tuberc Lung Dis 2000;4:534-40.
49. Medlar EM. Behavior of pulmonary tuberculous lesions: a pathological study. Am Rev Tuberc 1955;71:31.
50. Delacourt C, Mani TM, Bonnerot V, et al. Computed tomography with normal chest radiograph in tuberculous infection. Arch Dis Child 1993;69:430-2.
51. Smith MHD. What about short course and intermittent chemotherapy for tuberculosis in children? Pediatr Infect Dis 1982;1:298-303.
52. American Academy of Pediatrics. Tuberculosis. In: Pickering LK, editor. 2000 Red Book: Report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village (IL): American Academy of Pediatrics; 2000. p. 593-613.
53. Nakajo MM, Rao M, Steiner P. Incidence of hepatotoxicity in children receiving isoniazid chemoprophylaxis. Pediatr Infect Dis J 1989;8:649-50.
54. Kopanoff DE, Snider DE, Caras GJ. Isoniazid-related hepatitis: a United States Public Health Service Cooperative Surveillance Study. Am Rev Respir Dis 1978;117:991-1001.
55. Linna O, Uhari M. Hepatotoxicity of rifampicin and isoniazid in children treated for tuberculosis. Eur J Pediatr 1980;134:227-9.
56. Girling DJ. Adverse reactions to rifampicin in antituberculosis regimens. J Antimicrob Chemother 1977;3:115-32.
57. Salfinger M, Crowle AJ, Reller LB. Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system. J Infect Dis 1990;162:201-7.
58. Grosset JH. Present status of chemotherapy for tuberculosis. Rev Infect Dis 1989;11(Suppl 2):S342-7.
59. David HL. Probability distribution of the drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl Microbiol 1970;20:810-4.
60. Swanson DS, Starke JR. Drug-resistant tuberculosis in pediatrics. Pediatr Clin North Am 1995;42:553-80.
61. Mahmoudi A, Iseman M. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. JAMA 1993;270:65-8.
62. Nemir RL, O'Hare D. Tuberculosis in children 10 years of age and younger: three decades of experience during the chemotherapeutic era. Pediatrics 1991;88:236-41.
63. Hsu KHK, Starke JR. Diagnosis and treatment of tuberculous infection. Semin Pediatr Infect Dis 1993;4:283-90.
64. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ 1982;60:555-64.
65. Comstock GW. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 1999;3:847-50.
66. Gordin FM, Chaisson RE, Matts JP, et al. An international, randomized trial of rifampin and pyrazinamide versus isoniazid for prevention of tuberculosis in HIV-infected persons. JAMA 2000;283:1445-50.
67. Ormerod LP. Rifampicin and isoniazid prophylactic chemo therapy for tuberculosis. Arch Dis Child 1998;78:169-71.
68. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom. Thorax 1998;53:536-48.
69. American Thoracic Society and Centers for Disease Control and Prevention. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:1359-74.
70. Acocella G, Angel SH. Short-course chemotherapy of pulmonary tuberculosis: a new approach to drug dosages in the initial intensive phase. Am Rev Respir Dis 1986;134:1283-6.
71. Snider DE, Graczyk J, Bek E, et al. Supervised six-months treatment of newly diagnosed pulmonary tuberculosis using isoniazid, rifampin, and pyrazinamide with and without streptomycin. Am Rev Respir Dis 1984;130:1091-4.
72. Combs DL, O'Brien RJ, Geiter LJ. USPHS tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity and acceptability. Ann Intern Med 1990;112:397-406.
73. Aquinas SM. Short-course therapy for tuberculosis. Drugs 1982;24:118-32.
74. British Thoracic Society. A controlled trial of 6 months' therapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. Br J Dis Chest 1984;78:330-6.
75. Kumar L, Dhand R, Singhi PD, et al. A randomized trial of fully intermittent vs daily followed by intermittent short-course chemotherapy for childhood tuberculosis. Pediatr Infect Dis J 1990;9:802-6.
76. Varudkar BL. Short-course chemotherapy for tuberculosis in children. Indian J Pediatr 1985;52:593-7.
77. Abernathy RS, Dutt AK, Stead WW, et al. Short-course chemotherapy for tuberculosis in children. Pediatrics 1983;72:801-6.
78. Visudhiphan P, Chiemchanya S. Tuberculous meningitis in children: treatment with isoniazid and rifampin for twelve months. J Pediatr 1989;114:875-9.
79. Girgis NI, Fariz Z, Kilpatrick ME, et al. Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J 1991;10:179-82.
80. Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis 1997;25:872-87.
81. Bloch A, Cauthen G, Onorato I, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994;271:665-71.
82. Centers for Disease Control and Prevention. National action plan to combat multidrug-resistant tuberculosis. MMWR 1992;41:5-50.
83. Moore M, Onorato IM, McCray E, et al. Trends in drug-resistant tuberculosis in the United States, 1993-1996. JAMA 1997;278:833-7.
84. Centers of Disease Control and Prevention. The role of BCG vaccines in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Committee for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR 1996;45 (RR-4):1-18.
85. Goble M, Iseman MD, Madsen LA, et al. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993;328:527-32.
86. Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993;329:784-91.
87. Graham SM, Daley HM, Banerjee A, et al. Ethambutol in tuberculosis: time to reconsider? Arch Dis Child 1998;79:274-8.
88. Hampel B, Hullmann R, Schmidt H. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use - safety report. Pediatr Inf Dis J 1997;16:127-9.
89. Connelly KK. Prevention and public health aspects of tuberculosis. Pediatr Ann 1993;22:605-11.
90. Addington WW. Patient compliance: the most serious remaining problem in the control of tuberculosis in the United States. Chest 1979;76(suppl):741-3.
91. Fox W. Self-administration of medicaments: a review of published work and a study of the problems. Bull Int Union Against Tuberc 1962;32:307-31.
92. Burman WJ, Dalton CB, Cohn DL, et al. A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis. Chest 1997;112:63-70.
93. Snider DE, Bloch AB. Congenital tuberculosis. Tubercle 1984;65:81-2.
94. Franks AL, Binkin NJ, Snider DE, et al. Isoniazid hepatitis among pregnant and postpartum Hispanic patients. Pub Health Rep 1989;104:151-5.
95. Denby M, Banks J, Coody D, et al. Infant born to a mother with a positive tuberculin skin test - practice guidelines. J Pediatr Health Care 1996;10:31-4.
96. Snider DE, Powel KE. Should women taking antituberculosis drugs breastfeed? Arch Intern Med 1984;144:589-90.
97. Vallejo JG, Starke JR. Tuberculosis and pregnancy. Clin Chest Med 1992;13:693-706.
98. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 2nd ed. Geneva: World Health Organization; 1997.
99. Volmink J, Matchaba P, Garner P. Directly observed therapy and treatment adherence. Lancet 2000;355:1345-50.
100. Driver CR, Valway SE, Cantwell ME, et al. Tuberculin skin test screening of school children in the United States. Pediatrics 1996;98:97-102.
101. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis: metaoanalysis of the published literature. JAMA 1994;271:698-702.
102. Rodriques LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993;22:1154-8.
103. Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 1995;96:29-35.